These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34939311)

  • 1. Clinical significance of FAT1 gene mutation and mRNA expression in patients with head and neck squamous cell carcinoma.
    Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Ko SG; Eun YG
    Mol Oncol; 2022 Apr; 16(8):1661-1679. PubMed ID: 34939311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cancer stem cell gene expression signatures and prognosis in head and neck squamous cell carcinoma.
    Kim SI; Woo SR; Noh JK; Lee MK; Lee YC; Lee JW; Kong M; Ko SG; Eun YG
    BMC Cancer; 2022 Oct; 22(1):1077. PubMed ID: 36261806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
    Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
    Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival.
    Lin SC; Lin LH; Yu SY; Kao SY; Chang KW; Cheng HW; Liu CJ
    Carcinogenesis; 2018 Dec; 39(11):1320-1330. PubMed ID: 30102337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
    Kim KT; Kim BS; Kim JH
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2021-9. PubMed ID: 26876381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAT1 as a tumor mutation burden specific gene affects the immunotherapy effect in head and neck squamous cell cancer.
    Cao H; Lan T; Kuang S; Wang L; Li J; Li Q; Li Y; Xu Q; Chen Q; Ren S; Lan C; Ouyang N; Liao J; Huang Y; Li J
    Drug Resist Updat; 2024 Sep; 76():101095. PubMed ID: 38986165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy.
    León X; Llansana A; Pérez-Ugarte L; García J; Valero C; Quer M; Camacho M
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):359-364. PubMed ID: 37931687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
    Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
    Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP
    Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus RNA Transcript Associates with Prognosis in Non-human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma.
    Tang B; Zhu G; Chen C; Zheng S; Pu Y; Xu Y; Huang H; Wang G; Huang D; Liu Y; Zhang X
    Laryngoscope; 2021 Aug; 131(8):1774-1781. PubMed ID: 33592124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies.
    Martin D; Abba MC; Molinolo AA; Vitale-Cross L; Wang Z; Zaida M; Delic NC; Samuels Y; Lyons JG; Gutkind JS
    Oncotarget; 2014 Oct; 5(19):8906-23. PubMed ID: 25275298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 18. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC.
    Xin W; Zhao C; Jiang L; Pei D; Zhao L; Zhang C
    Pathol Oncol Res; 2021; 27():585192. PubMed ID: 34257533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Significance of the
    Lee MK; Noh JK; Woo SR; Kong M; Lee YC; Lee JW; Ko SG; Eun YG
    Cancer Genomics Proteomics; 2022; 19(5):591-605. PubMed ID: 35985688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.